| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |